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Physical stimulation of airway surfaces evokes liquid secretion, but
the events that mediate this vital protective function are not
understood. When cystic fibrosis transmembrane conductance reg-
ulator (CFTR) channel activity was used as a functional readout, we
found signaling elements compartmentalized at both extracellular
and intracellular surfaces of the apical cell membrane that activate
apical Cl conductance in Calu-3 cells. At the outer surface, ATP was
released by physical stimuli, locally converted to adenosine, and
sensed by A2B adenosine receptors. These receptors couple to G
proteins, adenylyl cyclase, and protein kinase A, at the intracellular
face of the apical membrane to activate colocalized CFTR. Thus,
airways have evolved highly efficient mechanisms to ‘‘flush’’
noxious stimuli from airway surfaces by selective activation of
apical membrane signal transduction and effector systems.
A irways continuously remove noxious materials through amucociliary clearance process that requires liquid secretion
(1, 2). cAMP-regulated cystic fibrosis transmembrane conduc-
tance regulator (CFTR) Cl channels (3, 4) are expected to
participate in liquid secretion in airways, but the two key events
in the activation of CFTR by local physical stimuli remain
puzzling. First, how do physical stimuli initiate the classic cAMP
signaling cascade, a process that is tightly regulated by G-
protein-coupled receptors (5)? Second, how does cAMP reach
CFTR in the apical membrane? The dogma of G-protein-
coupled receptors and adenylyl cyclase (AC) restricted to the
basolateral membrane of epithelia does not adequately explain
how these events occur (6).
Two ongoing areas of research suggest a potentially more
relevant, but as yet not fully tested model for activation of apical
CFTR by a local physical stimulus. Airway surface epithelia are
poorly innervated, suggesting that mucociliary clearance is sub-
ject to autocrineparacrine control. A leading candidate for
mediating mucociliary clearance is the release of cellular nucle-
otides, because release occurs in response to physical stimuli and
luminal nucleotide receptors stimulate apical Cl conductance,
mucus secretion, and ciliary beating (7, 8). The action of
ectonucleotidases extends the signaling potential of released
ATP on luminal surface by producing adenosine (Ado), a ligand
for A2 receptors that couple to AC (9, 10). Recent reports
indicate that receptors, intracellular signaling pathways, and
scaffolding molecules can form complexes that locally regulate
functions in subcellular compartments (11, 12). Thus, a model
linking a luminal physical stimulus to activation of CFTR
requires specific elements, including ATP release, ectonucleoti-
dases, Ado receptors, G proteins, and AC, to be intimately
associated with the apical cell membrane. The goal of the present
study was to test this hypothesis in polarized airway epithelial
cells.
Methods
Cells. Human Calu-3 cells were grown as previously described
(13) on Costar clear transwells (for HPLC and cAMP assay) or
homemade permeable supports (diameter was 1.5 cm for Ussing
chambers and 1.5 mm for patch-clamp studies) to confluence
with a resistance greater than 100 ohmcm2.
HPLC Analysis of Ado and Its Nucleotides. Calu-3 epithelia were
washed three times with Hanks’ balanced salt solution buffer and
loaded with 0.5 ml of buffer on the luminal surface. After 3 h at
37°C, 0.3 ml of the surface liquid was carefully collected for
HPLC analysis. Adenine-containing species were derivatized
with 2-chloroacetaldehyde (14), and the resulting fluorescent
1,N6-ethenopurines were separated by HPLC.
Cl Secretory Response to Luminal Hypotonic Challenge. Single-
barreled microelectrodes were pulled on a horizontal pipette
puller (P5, Narishige, Tokyo) from borosilicate glass (GC 120F,
Clarke Electromedical Instruments, Pangbourne, UK) and filled
with 3 M KCl. To impale the mucosal surface liquid of Calu-3
epithelia, a macroelectrode (3 M KCl-filled agar bridgecalomel
half-cell; World Precision Instruments, Sarasota, FL) was placed
in the serosal bath and the microelectrode was positioned by
micromanipulator into the mucosal surface liquid so that stable
transepithelial potential difference measurements could be re-
corded with an electrometer (FD 223, World Precision Instru-
ments). Measurements were made over an 10-min period after
the addition of 20 l of hypotonic Ringer’s solution (200 mOsm)
with or without adenosine deaminase (1 unit/ml) to the mucosal
surface. Perfluorocarbon (FC-77, 3M Co.) was added to the
mucosal surface before and after the addition of Ringer’s
solution to avoid evaporation of the surface liquid. All experi-
ments were performed at 37°C.
Ussing Chamber Studies. CFTR-mediated Cl secretion was mea-
sured as described (15). Briefly, cells grown on collagen mem-
brane supports were mounted in conventional Ussing chamber
devices. The submucosal bathing solution was Krebs bicarbonate
Ringer’s solution (KBR) and the mucosal solution was low-Cl
(3 mM) KBR. Bioelectric properties were digitally recorded
from the output of voltage clamps (Physiologic Instruments, San
Diego, no. VCC600) by using ACQUIRE software (Physiologic
Instruments). Voltage was clamped to 0 mV, except for 3-sec
pulses to  10 mV every 60 sec. Tissue conductance was
calculated from the resulting current deflections. For each
experiment, basal properties were recorded for 20–40 min. Test
compounds (Ado, Ado analogs, A2 antagonists, etc.) were
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added to the low-Cl luminal bath. Maximum cAMP-dependent
Isc (short circuit current) was recorded after bilateral exposure
to 10 M forskolin. Relative potency was determined by fitting
curves to the fractional changes induced by sequential increasing
concentrations of test substances, relative to the response to
forskolin. These conditions resulted in a basal CFTR-mediated
Isc of 30 to 40 Amp/cm2 and a maximally stimulated CFTR
current of 150–200 A/cm2.
Intracellular cAMP Assay. Calu-3 epithelia were washed three
times (160 mM TrisCl30 mM sucrose, pH 7.0), and incubated
with the same buffer plus 0.3 mM adenosine 5-[,-
methylene]diphosphate (AMPCP) for 45 min at room
temperature. Subsequently, 1 M Ado or 1 M forskolin was
added into the luminal bath. After 8 min, cells were lysed
and intracellular cAMP was measured by an enzyme immu-
noassay kit.
Single-Channel Studies. CFTR Cl channel activity was recorded
at a membrane potential of 60 mV (13).
Cell-attached recording. Both the pipette and the bath con-
tained 160 mM TrisCl and 30 mM sucrose, pH 7.0. The
resistance of an open pipette was 6–8 M. Compounds tested
only in the pipette were added to pipette solution and CFTR
channel activity was recorded 300 s after seal formation. Tests of
Ado or forskolin outside the pipette were made by cumulative
additions to the bath, as indicated.
Outside-out recording. Pipettes were filled with 40 mM TrisCl
100 mM Trisgluconate2 mM MgCl25 mM Tes1 mM EGTA
0.1 mM CaCl21 mM MgATP0.2 mM LiGTP, pH 7.4. The bath
buffer was 150 mM TrisCl2 mM MgCl1 mM CaCl25 mM
Tes30 mM sucrose10 mM D-glucose, pH 7.4. After formation
of outside-out patches, CFTR channel activity was recorded for
300 s. Ado was then added into the bath and channel activity was
recorded for 300–400 s.
Inside-out recording. Pipette and bath solutions were the same
as in the cell-attached recording, and 1 mM MgATP was added
in the bath solution. CFTR activity was recorded for 300 s after
inside-out patch excision, and then forskolin was added to
the bath.
AMPCP was present at 0.3 mM in both pipette and bath
solutions in all experiments, except for some experiments in Fig.
2A. The product of CFTR channel number (N) and open
probability (po) was calculated as CFTR channel activity. For
experiments in Fig. 2 A and C, Npo was calculated from 300 s of
recording for each experiment. For all other experiments, con-
trol Npo was calculated from the 100 s recorded before test
compound exposure. For each test condition, Npo was calculated
from the 100-s segment (of 300 s) with the highest Npo.
Statistics. All of the data were expressed as means  SE and the
Student’s t test was used for statistical analysis.
Reagents. ATP, GTP, and the enzymeimmunoassay kit were
from Amersham Pharmacia. Guanosine 5-[-thio]diphosphate
(GDPS) and guanosine 5-[-thio]triphosphate (GTPS) were
from Boehringer Mannheim. Other reagents were obtained
from Sigma.
Fig. 1. CFTR regulation by mucosal Ado. (A) HPLC profile of ethenoadenosine (-Ado) and its nucleotides in the mucosal surface liquid media of Calu-3 cells.
The -adenosine peak was identified by -adenosine standards and by its sensitivity to 1 unit/ml adenosine deaminase (ADA). y axis, fluorescence in arbitrary units.
The amount of ethenopurines in the total 0.5 ml of luminal surface liquid were as follows: -Ado, 16 pmol; -AMP, 9 pmol; -ADP, 28 pmol; and -ATP, 4 pmol.
(B) Cl secretory response to mucosal hypotonic challenge. (C) Cl secretion by polarized Calu-3 cells in response to Ado and Ado analogs. Responses to cumulative
increases in ligand concentration in the mucosal bath solution are expressed as a percent of the 10 M forskolin response (solid lines). Dose–effect relationships
were also performed in the presence the Ado receptor antagonist 8-(p-sulfophenyl)theophylline (8-SPT; 100 M) (dashed lines). NECA, 5-N-
ethylcarboxamidoadenosine; CGS, CGS-21680 (n  3). (D) cAMP accumulation and Cl secretion. Cl secretion stimulated by 1 M Ado or 1 M forskolin are
expressed as a percent of the 10 M forskolin response (Fractional Response) as in C. The intracellular cAMP concentrations are expressed as fold over control
(n  3 or 4). *, Different from control, P  0.001.








We tested for compartmentalized regulation of CFTR by Ado in
Calu-3 cells, a model of serous cells, which are thought to play
a critical role in liquid secretion and pathogenesis of cystic
fibrosis in human airways (16, 17). We began by asking if Ado
was present in airway surface liquid under basal conditions.
Liquid sampled from the nondisturbed apical surface of Calu-3
epithelia contained ATP as well as ADP, AMP, and Ado (Fig.
1A), consistent with basal release and metabolism of cellular
ATP on the luminal surface (18). Moreover, a hypotonic stim-
ulus stimulated Cl secretion and this change was prevented by
adenosine deaminase (Fig. 1B), which removed Ado from the
luminal compartment (Fig. 1 A and B). Because Calu-3 cells do
not express P2Y2 receptors (19), this result suggested that the
released ATP was metabolized by ectonucleotidases to Ado, a
ligand for A2 receptors that couple to AC (9, 10, 20). We tested
this possibility by exposing the luminal surface of Calu-3 epi-
thelia to Ado analogs in Ussing chambers. Cl secretion was
stimulated with a rank order potency (5-N-ethylcarboxamidoad-
enosine  Ado  CGS-21680) and inhibitor sensitivity (8-SPT),
consistent with luminal A2B adenosine receptors (A2BAR) reg-
ulating CFTR through a Gs–AC–protein kinase A (PKA) path-
way (10, 21) (Fig. 1C). However, when we correlated the effect
of luminal Ado on Cl secretion with cAMP production, we
found that 1 M Ado, the approximate ED50 concentration for
stimulation of Cl secretion (Fig. 1C), barely increased produc-
tion of cAMP. In contrast, 1 M luminal forskolin stimulated no
more Cl secretion than 1 M Ado, but produced 9 times more
cAMP (Fig. 1D).
The efficient stimulation of Cl secretion by Ado with little
change in cAMP level could signify highly localized regulation of
CFTR by A2BAR in the apical cell membrane. To better evaluate
this possibility we recorded the single-channel activity of CFTR
in the apical membranes of polarized Calu-3 cell epithelia under
defined patch-clamp conditions. During cell-attached recording
with 1 M exogenous Ado in the pipette, CFTR NPo was nearly
2-fold greater than basal NPo (Fig. 2A). However, the effect only
approached statistical significance despite a large sample size
Interestingly, CFTR NPo was markedly decreased when the
pipette contained an inhibitor of Ado formation, AMPCP (9), or
the Ado receptor antagonist 8-SPT (Fig. 2 A). Thus, a significant
fraction of CFTR activity during basal cell-attached recording
conditions is due to endogenous Ado production at the external
patched surface. With AMPCP present to limit this production
of endogenous Ado, exogenous 1 M Ado in the pipette caused
a dramatic stimulation of CFTR NPo and 8-SPT blocked this
action (Fig. 2 B and C). Therefore, A2BAR within an apical
cell-attached membrane patch sense Ado and signal to CFTR
Cl channels contained within the same patch. This signaling
between Ado at the extracellular surface and CFTR was tightly
compartmentalized because 100 M Ado added to the bath
outside the pipette had no effect on CFTR activity within
cell-attached patches (Fig. 2 D and E). As a control, CFTR in
these same patches was robustly stimulated by the cell-permeant
diterpene forskolin (10 M), which we found to cause a large
increase in total intracellular cAMP (Fig. 2 D and E).
Fig. 2. Exogenous and endogenous adenosine stimulates CFTR in cell-attached patches. (A) CFTR cell-attached Npo recorded under control conditions (Ctrl; n 
26) or when the pipette contained 1 M exogenous Ado (n  18), 300 M AMPCP (present in the bath as well; n  28), or 100 M 8-SPT (n  15). *, Different
from control (P  0.05). (B) Effect of exogenous Ado on CFTR channel activity with AMPCP in the pipette and the bath. Numbers and dashes at the left indicate
active channel number. (C) Summary data for B. Ctrl (n  28); 1 M Ado (n  28); 1 M Ado 	 100 M 8-SPT (n  16). *, Different from Ctrl, P  0.02. (D) Effect
of adenosine added to the bath on CFTR contained in cell-attached patches. Continuous trace showing CFTR activity recorded in the cell-attached mode before
and during sequential exposure to 1 and 100 M Ado, followed by 10 M forskolin. (E) Summary data for D. (n  9). *, Different from Ctrl, P  0.05.
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Our cell-attached recordings of CFTR in the apical membrane
identified A2BAR to CFTR signaling in a near membrane or
subapical compartment. To better localize key cAMP-signaling
elements, we excised apical membrane patches from polarized
Calu-3 cells and used CFTR activity as a functional assay for G
proteins, AC, and PKA. In outside-out apical membrane patches
with 200 M LiGTP in the pipette solution to approximate the
cytosolic GTP concentration, sequential exposure to 1 M and
10 M Ado stimulated CFTR (Fig. 3A). In outside-out patches
formed with a PKA inhibitor (PKI) in the pipette, CFTR basal
activity was markedly reduced and Ado had no effect (Fig. 3A
Inset). PKI sensitivity of Ado stimulation places functional PKA
downstream of A2BAR and demonstrates that cAMP-signaling
between A2BAR and CFTR is functionally intact in isolated
patches of apical cell membrane.
G proteins have been reported to affect CFTR in whole-cell
conditions through implied actions on AC (22). When we formed
outside-out patches with 200 M GTP replaced by GDP, Ado no
longer stimulated CFTR (Fig. 3B). GDPS in the pipette caused
even lower basal CFTR activity and abrogated the response to
extracellular Ado (Fig. 3B). Stimulation of CFTR by Ado was
fully supported, however, by just 10 M GTPS in the pipette
solution (Fig. 3B). These results demonstrate a role for Gs in the
regulation of CFTR in excised membrane patches, and reveal
physical and functional association of this key element of the
cAMP-signaling cascade with the inner apical membrane
surface.
G-protein-dependent, PKA-mediated activation of CFTR by
A2BAR in excised patches implies that the integral membrane
protein AC is present and functional in the apical membrane of
Calu-3 cells. AC expression in the apical membrane of epithelia
is controversial (23–27). Therefore, we tested whether condi-
tions that modulate AC affect Ado regulation of CFTR in
excised apical membrane patches. When the P-site inhibitor of
AC, SQ-22536 (28), was included in the pipette solution used
with outside-out patches, we recorded very low basal CFTR
activity and detected no increase in NPo in response to extra-
cellular Ado (Fig. 4A, compare with Fig. 3A). As a second
approach, patches containing CFTR were excised in the inside-
out configuration into a bath that contained 1 mM MgATP.
After 5 min, channel activity typically ‘‘ran down.’’ However, the
addition of 10 M forskolin, which directly stimulates AC, to the
bath increased CFTR activity; this stimulation was blocked by
PKI (Fig. 4B). SQ-22536 sensitivity of Ado regulation of CFTR
and forskolin stimulation of CFTR by means of activation of
endogenous PKA functionally demonstrate AC activity in the
apical membrane.
Discussion
The distinctive polarized distribution of ion channels and trans-
porters in epithelia that enables vectoral solute transport has
fostered great interest in apical versus basolateral targeting
mechanisms. However, descriptions of the signal transduction
pathways that are necessary to selectively regulate functions
localized in the apical or basolateral cell membranes have been
lacking (29). An attractive hypothesis is that polarized trans-
porters are efficiently regulated by signal transduction machin-
ery appropriately colocalized at the apical or basolateral mem-
brane. Testing for such compartmentalization by biochemical
methods that disrupt polarity has proved problematic (23, 26,
27). Similarly, immunohistochemical methods often lack the
sensitivity to detect a small pool of functionally important
proteins localized in a subcellular domain, such as the apical
membrane (23–25). Here, we have used patch-clamp technique
to physically isolate apical cell membranes, and we have used
CFTR single-channel activity as a functional reporter to identify
cAMP signaling elements that are present. Our results reveal
surprisingly intact A2BAR coupling to CFTR in cell-free apical
membrane patches that was sensitive to GTP, to an inhibitor of
AC, and to PKI.
Our results support a model that accounts for activation of
CFTR Cl conductance in the apical membrane by local physical
stimuli (Fig. 5). Although we initiated our studies to identify
compartmentalized intracellular signaling elements, it became
clear that recognition of a local physical stimulus involves
organized signaling on the extracellular surface as well. The path
begins with release of cellular ATP onto the luminal surface, a
process known to occur in response to diverse physical stimuli
(18, 30). Although we do not address the identity of the
mechanism(s) responsible for ATP release, our HPLC data (Fig.
1A) are consistent with a nonstimulated constitutive release that
could be increased by diverse physical stimuli (8, 18). ATP on the
luminal surface of Calu-3 cells is converted to Ado. This
Fig. 3. Regulation of CFTR by extracellular adenosine in excised, outside-out
apical membrane patches. (A Upper) Representative trace showing activation
of CFTR by extracellular Ado. After 300-s basal recording, Ado addition to the
bath is indicated by the arrows, first at 1 M for 300–400 s, and then at 10 M
for 300 s. (Lower) Summary data for 3A Upper (n  9). *, Different from
control, P  0.05. (Inset) Effect of PKI (10 M in pipette) on 1 M Ado on CFTR
activity (n  6). (B) Effect of 1 M Ado on CFTR activity when the pipette
contained 200 M GDP (n  12), 100 M GDPS (n  7), or 10 M GTPS (n 
11). *, Different from Before ADO, P  0.05.







conversion likely utilizes several ecto-enzymatic activities capa-
ble of dephosphorylating nucleotides. Inhibition of basal CFTR
NPo by AMPCP and by 8-SPT reveals that Ado generated on the
surface of Calu-3 cells activates A2BAR in the apical membrane.
Thus, ATP release and metabolism at the extracellular cell
surface constitutes a link between a physical stimulus and the
intracellular signaling machinery linked to cAMP generation.
At the inner apical membrane surface, A2BAR are coupled to
CFTR by means of Gs, AC, and PKA. Activation of CFTR by
Ado added to the extracellular face of excised, outside-out
patches of apical membrane revealed that the intact cAMP-
signaling path from receptor to final effector was closely asso-
ciated with the apical membrane. This interpretation was
strengthened by our observations that individually manipulating
elements of the pathway affected CFTR activity in excised
membrane patches. For example, PKI inhibited signaling, indi-
cating that, as we reported previously (13), PKA exists in excised
apical membranes. The pathway was also disrupted by GDP and
GDPS, which are expected for an intact signaling path from
A2BAR through Gs (10). Our results also predicted that PKA
associated with the excised membrane patch was being activated
by locally generated cAMP. In accordance with this prediction,
a P-site inhibitor of AC completely blocked activation of CFTR
by extracellular Ado. In separate experiments, we showed that
Fig. 4. CFTR is regulated by apical AC activity. (A Upper) Effect of Ado on CFTR in excised, outside-out patches with the AC inhibitor SQ22,536 in the pipette
solution. (Lower) Summary for seven experiments like those in Upper. Note expanded scale for Npo. (B Upper) Single-channel recordings in excised, inside-out
patches showing effect of forskolin (FSK) on CFTR in the absence and presence of PKI. (Lower) Summary data for effect of forskolin alone (Ctrl, n  12) or in the
presence of 10 M PKI (n  5); *, P  0.02.
Fig. 5. Compartmentalized cAMP-signaling elements on the extracellular and intracellular surfaces of the apical cell membrane. Model depicts how diverse
physical stimuli (e.g., hypotonicity and shear stress) regulate CFTR. After release of ATP onto the extracellular surface, Ado is generated by ectonucleotidases
(NT). A2B receptors bind Ado and activate AC present in the apical membrane by means of Gs. Sufficient cAMP is generated locally to activate PKA in a diffusionally
restricted apical microdomain, but not in other cellular compartments. AKAP, A-kinase anchoring protein.
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CFTR could be activated by exposure of inside-out patches to
the AC activator forskolin. Therefore, we were able to observe
functional evidence for a path from A2BAR to CFTR that
included G proteins, AC, and PKA in apical membrane patches
excised from polarized Calu-3 cells.
Our functional evidence of AC in the apical membrane of
epithelial cells might be viewed as somewhat surprising, because
AC is traditionally viewed as a marker of epithelial basolateral
membrane (31, 32). However, our functional approach may be
much more sensitive than biochemical or immunocytochemical
assays. Importantly, AC function in the apical membrane greatly
simplifies models proposed to explain how G-protein-coupled
receptors (GPCR) in the apical membrane of epithelia signal to
effectors in the same membrane. Specifically, with AC in the
apical membrane, it is not necessary to postulate that apical
GPCR generate diffusible mediators (Gs, cAMP) for the signal
to literally crisscross the cell (33–35). Combined with our
previous finding of PKA anchored at the apical membrane by
association with A-kinase anchoring proteins (13), the presence
of AC in the apical membrane completes a classic GPCR
pathway for activated G proteins to regulate apical effectors.
To the best of our knowledge, our finding of membrane-
delimited cAMP signaling in the present study is unprecedented.
A long-held dogma in the field of ion channel regulation is that
signaling from GPCR to ion channels in cell free patches involves
no readily diffusible second messenger (36–38). When such
‘‘membrane-delimited’’ signaling is coupled with a lack of
change in whole cell second messenger levels, the results are
often interpreted as direct modulation of ion channels by G
proteins (39). This has been challenged by recent findings that
membrane-delimited signaling may involve protein kinase C-
mediated phosphorylation (38, 40, 41). However, there is no
report showing receptor to ion channel effector regulation in
excised membrane patches by an intact classic cAMP pathway,
either in epithelia or any other tissues. This is a little unexpected,
as there is rich information regarding compartmentalization of
PKA with its protein targets, and similarly, of receptors with G
proteins. However, we know of no other report of AC close to
PKA. The presence of AC in apical membrane patches that
contain PKA permits very local cAMP-mediated regulation of
CFTR.
In summary, the model presented in this work (Fig. 5)
addresses two general problems faced by airway and other
barrier epithelial cells. The first is how to regulate effectors in
response to physical stimuli for which no specific receptor exists.
Diverse physical stimuli are known to release cellular ATP (42,
43). Subsequent conversion of ATP to Ado by ectonucleotidases
is, in effect, an extracellular signal transduction pathway through
which any stimulus that triggers ATP release can be recognized
by an apically localized receptor-driven cAMP-signaling path-
way. A second problem for epithelial cells is how to selectively
activate the apical functions needed for protective response to
luminal stimuli. The dramatically limited spread of cAMP
signaling we observed in response to apical A2BAR activation
suggests that compartmentalization of cAMP signaling at the
inner apical membrane surface allows cells to sensitively regulate
apical effectors without global activation of signaling paths that
target other cell functions.
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